Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and pharmacologic characterization of the rat 6 Hz model of partial seizures
Cameron S. Metcalf, Peter J. West, Kyle Thomson, et al.
Epilepsia (2017) Vol. 58, Iss. 6, pp. 1073-1084
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 3, pp. 606-638
Open Access | Times Cited: 621
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
Pabitra Hriday Patra, Melissa Barker‐Haliski, H. Steve White, et al.
Epilepsia (2018) Vol. 60, Iss. 2, pp. 303-314
Open Access | Times Cited: 137
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
Yi Wang, Chen Zhong
Pharmacology & Therapeutics (2019) Vol. 201, pp. 77-93
Closed Access | Times Cited: 127
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 86
Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice
Ariadna Amador, Christopher D. Bostick, Heather E. Olson, et al.
Brain (2020) Vol. 143, Iss. 7, pp. 2039-2057
Open Access | Times Cited: 73
Butyrate alleviates PTZ-induced mitochondrial dysfunction, oxidative stress and neuron apoptosis in mice via Keap1/Nrf2/HO-1 pathway
Dongyue Li, Xinying Bai, Yuan Jiang, et al.
Brain Research Bulletin (2020) Vol. 168, pp. 25-35
Closed Access | Times Cited: 73
Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments
Wolfgang Löscher, H. Steve White
Cells (2023) Vol. 12, Iss. 9, pp. 1233-1233
Open Access | Times Cited: 38
The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy
Karen S. Wilcox, Peter J. West, Cameron S. Metcalf
Neuropharmacology (2019) Vol. 166, pp. 107811-107811
Open Access | Times Cited: 70
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening
Melissa Barker‐Haliski, H. Steve White
Neuropharmacology (2019) Vol. 167, pp. 107750-107750
Open Access | Times Cited: 64
1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy
Barbara Kaproń, Robert Czarnomysy, Mariusz Wysokiński, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 993-1002
Open Access | Times Cited: 45
Current advances in rodent drug-resistant temporal lobe epilepsy models: Hints from laboratory studies
Shuo Zhang, Shengyang Xie, Yang Zheng, et al.
Neurochemistry International (2024) Vol. 174, pp. 105699-105699
Closed Access | Times Cited: 5
In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy
Gonçalo Campos, Ana Fortuna, Amílcar Falcão, et al.
Epilepsy Research (2018) Vol. 146, pp. 63-86
Closed Access | Times Cited: 43
Preclinical evaluation of 1,2,4-triazole-based compounds targeting voltage-gated sodium channels (VGSCs) as promising anticonvulsant drug candidates
Barbara Kaproń, Jarogniew J. Łuszczki, Agata Siwek, et al.
Bioorganic Chemistry (2019) Vol. 94, pp. 103355-103355
Open Access | Times Cited: 37
Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it
Krzysztof Łukawski, Stanisław J. Czuczwar
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 9, pp. 1075-1090
Closed Access | Times Cited: 29
A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
Melissa Barker‐Haliski, Lauren C. Harte‐Hargrove, Teresa Ravizza, et al.
Epilepsia Open (2018) Vol. 3, Iss. S1, pp. 53-68
Open Access | Times Cited: 34
A facile synthesis of 1,3,4-oxadiazole-based carbamothioate molecules: Antiseizure potential, EEG evaluation and in-silico docking studies
Nasır Rasool, Zainib Razzaq, Samreen Gul Khan, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 4, pp. 104610-104610
Open Access | Times Cited: 10
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice
Ezgi Özcan, Kristie B. Yu, Lyna Dinh, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
ENX‐101, a GABAA receptor α2,3,5‐selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models
Jordi Serrats, Krishna C. Vadodaria, William D. Brubaker, et al.
Epilepsia (2025)
Open Access
Exploring the Anticonvulsant Potential of Daucus carota L.: A Combined In Silico and In Vivo Study for Epilepsy Therapy Development
NarayanChandra Sarkar, A. V., Akshay Shamnewadi
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100610-100610
Open Access
Computational Attitudes to Drug Discovery in Epilepsy
Shama Mujawar, Aarohi Deshpande, Avni Bhambure, et al.
(2025), pp. 313-334
Closed Access
Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model
Cameron S. Metcalf, Jennifer Huff, Kyle Thomson, et al.
Epilepsia Open (2019) Vol. 4, Iss. 3, pp. 452-463
Open Access | Times Cited: 28
Evaluation of subchronic administration of antiseizure drugs in spontaneously seizing rats
Kyle Thomson, Cameron S. Metcalf, Thomas G. Newell, et al.
Epilepsia (2020) Vol. 61, Iss. 6, pp. 1301-1311
Open Access | Times Cited: 26
Screening of prototype antiseizure and anti‐inflammatory compounds in the Theiler's murine encephalomyelitis virus model of epilepsy
Cameron S. Metcalf, Fabiola Vanegas, Tristan K. Underwood, et al.
Epilepsia Open (2021) Vol. 7, Iss. 1, pp. 46-58
Open Access | Times Cited: 21
Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
Michał Abram, Marcin Jakubiec, Katelyn Reeb, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11703-11725
Open Access | Times Cited: 16
The Positive Allosteric Modulator ofα2/3-Containing GABAAReceptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury
Jeffrey M. Witkin, Guanguan Li, Lalit K. Golani, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 372, Iss. 1, pp. 83-94
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top